1. Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. (13th July 2017) Authors: Spring, Laura M.; Zangardi, Mark L.; Moy, Beverly; Bardia, Aditya Journal: Oncologist Issue: Volume 22:Number 9(2017) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. (September 2017) Authors: Spring, Laura M.; Zangardi, Mark L.; Moy, Beverly; Bardia, Aditya Journal: Oncologist Issue: Volume 22:Number 9(2017) Page Start: 1039 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. Issue 1 (1st January 2022) Authors: Naranbhai, Vivek; Pernat, Claire A.; Gavralidis, Alexander; St Denis, Kerri J.; Lam, Evan C.; Spring, Laura M.; Isakoff, Steven J.; Farmer, Jocelyn R.; Zubiri, Leyre; Hobbs, Gabriela S.; How, Joan; Brunner, Andrew M.; Fathi, Amir T.; Peterson, Jennifer L.; Sakhi, Mustafa; Hambelton, Grace; Denaul... Journal: Journal of clinical oncology Issue: Volume 40:Issue 1(2022) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer. (August 2022) Authors: Denault, Elyssa; Nakajima, Erika; Naranbhai, Vivek; Hutchinson, Jennifer A.; Mortensen, Lindsey; Neihoff, Elizabeth; Barabell, Caroline; Comander, Amy; Juric, Dejan; Kuter, Irene; Mulvey, Theresa; Peppercorn, Jeffrey; Rosenstock, Aron S.; Shin, Jennifer; Vidula, Neelima; Wander, Seth A.; Moy, Bev... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. (13th July 2021) Authors: Mortensen, Lindsey; Ordulu, Zehra; Dagogo-Jack, Ibiayi; Bossuyt, Veerle; Winters, Loren; Taghian, Alphonse; Smith, Barbara L.; Ellisen, Leif W.; Kiedrowski, Lesli A.; Lennerz, Jochen K.; Bardia, Aditya; Spring, Laura M. Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. (13th July 2021) Authors: Mortensen, Lindsey; Ordulu, Zehra; Dagogo‐Jack, Ibiayi; Bossuyt, Veerle; Winters, Loren; Taghian, Alphonse; Smith, Barbara L.; Ellisen, Leif W.; Kiedrowski, Lesli A.; Lennerz, Jochen K.; Bardia, Aditya; Spring, Laura M. Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014. Issue 3 (11th October 2016) Authors: Spring, Laura M.; Marshall, Megan R.; Warner, Erica T. Journal: Cancer Issue: Volume 123:Issue 3(2017) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. Issue 11 (2nd November 2017) Authors: Zangardi, Mark L.; Spring, Laura M.; Blouin, Gayle C.; Bardia, Aditya Journal: Expert review of clinical pharmacology Issue: Volume 10:Issue 11(2017) Page Start: 1169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?. (1st February 2019) Authors: Zangardi, Mark L.; Spring, Laura M.; Nagayama, Aiko; Bardia, Aditya Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 2(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities. (10th July 2021) Authors: Spring, Laura M.; Nakajima, Erika; Hutchinson, Jennifer; Viscosi, Elene; Blouin, Gayle; Weekes, Colin; Rugo, Hope; Moy, Beverly; Bardia, Aditya Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: 827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗